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Abstract:  
 
Ferrimagnetic glass-ceramics containing magnetite crystals were developed for hyperthermia 
applications of solid neoplastic tissue. The present work is focused on in vitro evaluation of the 
biocompatibility of these materials, before and after soaking in a simulated body fluid (SBF). X-ray 
diffraction, scanning electron microscopy, atomic absorption spectrophotometry, X-ray 
photoelectron spectrometry and pH measurements were employed in glass-ceramic characterisation. 
The free-radical mediated reactivity of the glass-ceramic was evaluated by Electron Paramagnetic 
Resonance (EPR) spin trapping. Cell adhesion and proliferation tests were carried out by using 3T3 
murine fibroblasts. Cytotoxicity was performed by qualitative evaluation of human bone 
osteosarcoma cells U2OS cell line. The results show that almost two times more 3T3 cells 
proliferated on the samples pre-treated in SBF, compared with the untreated specimens. Moreover a 
decrease of confluence was observed at 48 and 72 hours  for U2OS cells exposed to the untreated 
glass-ceramic, while the powder suspensions of glass-ceramic pre-treated in SBF did not influence 
the cell morphology up to 72h of exposition. The untreated glass-ceramic exhibited Fenton-like 
reactivity, as well as reactivity towards formate molecule. After pre-treatment with SBF the 
reactivity towards formate was completely suppressed. The concentration of iron released into the 
SBF solution was below 0.1 ppm at 37°C, during one month of soaking. The different in vitro 
behavior of the samples before and after SBF treatment has been correlated to the bioactive glass-
ceramic surface modifications as detected by morphological, structural and compositional analyses.  
 
 
Key words: ferrimagnetic, glass-ceramic, magnetite, cell culture, hyperthermia, cancer.  
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
3  
1. Introduction  
 
Magnetic materials are widely used for different biomedical applications such as magnetic 
resonance imaging contrast agents, immunoassay, detoxification of biological fluids, hyperthermia, 
drug delivery, cell separation, etc [1, 2]. More recently, magnetic materials (nanoparticles) have 
been included in the category of bio-targeted systems and therapeutic tools [3] which can be guided 
to target sites by means of an external magnetic field and subsequently heated for hyperthermia 
cancer therapy. Magnetic nanoparticles are assessed as both carriers for drugs and as contrast agents 
for magnetic resonance detection. All these applications require appropriate biological behaviour in 
terms of biocompatibility and non-toxicity. In vitro biological tests have general applicability and 
widespread use for evaluation of a large range of devices and materials, being a critical factor for 
biomedical applications. 
In the last decades, magnetic glass-ceramics have been developed for the magnetic induction of 
hyperthermia, which is one of the therapies for cancer treatment [4, 5, 6, 7, 8]. This method exploits 
the potential of magnetic materials to generate heat under an alternating magnetic field. The heat 
generation depends on the materials properties, magnetic field parameters and tissue characteristics 
[9]. Magnetic particles are implanted in the tumour site and an external oscillating magnetic field is 
applied. The magnetic materials will develop heat, raising the temperature of the surrounding tissue 
and thus, the cancer cells are damaged or destroyed [10].  
In our previous studies [11, 12, 13, 14] ferrimagnetic glass-ceramics with the composition in the 
system SiO2–Na2O–CaO–P2O5–FeO–Fe2O3 were obtained by two different synthesis methods: 
coprecipitation derived and traditional-melting derived. The microstructure, thermal and magnetic 
properties, bioactivity and specific power loss were analysed. Focusing the attention on the 
bioactivity mechanism of glasses and glass-ceramics [15], it was shown that it starts with a rapid 
ions exchange between the alkaline ions from the glass surface and the hydrogen ions from the 
solution. This step is followed by the formation of silanols on the surface of the glass, which then 
undergo polycondensation to form a silica gel layer. Silica gel promotes the adsorption of calcium 
and phosphate ions from the solution, which subsequently react, forming a hydroxyapatite layer. 
The first stages of bioactivity, up to the formation of silanols on the glass surface, give rise to a 
slight enhancement of pH values due to the depletion of the hydrogen ions in the solution. This 
feature can be also observed in solutions such as TRIS buffer or Kokubo’s simulated body fluid 
(SBF) [16] and should be carefully controlled when bioactive glass samples are placed in contact 
with different cell lines, during biological evaluations [17].  
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If iron oxides are present into the glass or glass-ceramic, some effort should be done to assess that 
ion leaching can occur without production of toxic ions in vivo, taking into account that, however, 
the body has a mechanism for the management of Fe
3+
, so its low-level release should not produce 
any toxic effects [18]. Moreover, when particles come in contact with cells and tissues, the 
interactions between particles surface and the living matter can have detrimental outcomes. As 
observed with toxic particulates including lunar dust simulants and volcanic ashes [19, 20], the 
presence of redox active centres (more likely iron) is responsible for the oxidative potential of such 
particulates. In particular, they can drive the release of reactive oxygen species (ROS), such as 
hydroxyl, superoxide and hydroperoxide radicals. A mechanism through which iron (or other redox-
active metals) centres are implied in the generation of HO• radical is the Fenton-like reaction which 
occurs in the presence of H2O2, as in the phagolysosomal vesicles after phagocytosis. A 
complementary reaction driven by redox active centres is the homolytic cleavage of the C-H bond 
of biomolecules (including lipids, proteins and nucleic acids).   
In this paper we focus on the surface reactivity and ion leaching of ferrimagnetic glass-ceramics in 
the system SiO2–Na2O–CaO–P2O5–FeO–Fe2O3, and on their biological properties by analysing the 
in-vitro biocompatibility on 3T3 murine fibroblasts and U2OS human bone osteosarcoma 
osteoblasts. Moreover, the capability of SC45 to generate HO• radicals via a Fenton-like reaction 
and to cleave the C-H bond of formate ion was investigated by electron paramagnetic resonance 
(EPR) spin trapping.     
 
2. Materials and methods 
 
2.1. Sample preparation  
A ferrimagnetic glass-ceramic with the nominal composition 24.7SiO2–13.5Na2O–13.5CaO–
3.3P2O5–14FeO–31Fe2O3 (wt.%) was obtained by a traditional melting method, quenching the melt 
from 1550°C melting temperature onto a rectangular brass mould as described in [12]. The resulted 
glass-ceramic, named SC45, contains magnetite crystals, embedded in an amorphous matrix. 
Magnetite crystals are formed during quenching. The obtained bars were annealed at 600 °C for 12 
hours and then were polished with SiC abrasive papers, up to 2400 grit. A part of the bars was cut in 
small slices (around 5 x 5 x 2mm
3
). Another part was ground in a planetary ball mill and the 
obtained powder was sieved under 20μm. 
 
2.2. Characterisation of the ferrimagnetic glass-ceramic 
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2.2.1. X-ray diffraction (XRD) 
X-ray diffraction (XRD) patterns were registered by a Philips X`Pert diffractometer with Cu K 
radiation, between 10° and 75° (2), at 40kV and 30 mA. The phase identification was performed 
by X'Pert HighScore program, with PCPDFWIN database.  
 
2.2.2. Scanning electron microscopy (SEM) 
The glass-ceramic morphology was analysed by scanning electron microscopy (SEM), using a FEI, 
QUANTA INSPECT 200 model. In order to analyse the crystals morphology, the polished glass-
ceramic bulk samples were first etched for 4min with a solution of 5% volume of HF:HNO3 in a 
molar ratio 1:1, and then coated by a thin layer of silver.  
 
2.2.3. pH analysis  
The variation of the pH during soaking the samples in 15ml SBF, prepared after Kokubo’s protocol 
[21] over one month period, was measured by a pocket sized pH-meter (Hanna Instruments). Both 
bulk and powder samples were used. The bulk samples had dimensions around 5 x 5 x 2 mm
3
, 
while the powders (0.2 g/sample) had the particles size less than 20 m. The samples were kept at 
37 °C in an incubator. The SBF solutions were refreshed twice a week for both powders and bulk 
samples. For the bulk samples, the pH was measured without refreshing the SBF solution. Four 
samples were used for each set of experiments and the average pH value was calculated.  
 
2.2.4. Atomic absorption spectrophotometry (AAS) 
Samples containing 0.2 g of SC45 powder were immersed in 15ml SBF solution and respectively 
distilled water, and kept at 37°C in an incubator for a maximum of four weeks. The variation of the 
concentration of Ca, Si, Na and Fe released during soaking the SC45 powder samples in both 
distilled water and SBF was measured by a Perkin-Elmer 1100B Atomic Absorption Spectrometer 
equipped with an air-acetylene flame burner. Each chemical element was measured individually. 
The experiments were performed in triplicate. 
 
2.2.5. X-ray photoelectron spectroscopy (XPS)   
X-Ray photoelectron spectroscopy (XPS) spectra were registered on a Surface Science Instrument 
(M-Probe) with a monochromatic Al Kα X-ray source. The detailed spectra of oxygen, carbon and 
silicon regions (O1s, C1s and respectively Si2p) were analysed separately. The take-off angle to the 
substrates was 90°, the pressure was approximative 10
−8 
Torr and the pass energy used to determine 
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the elemental composition was 30 eV. Two sets of bulk samples were analysed: SC45 samples 
before and after soaking in SBF for one week (samples denominated SC45+SBF).  
 
2.2.6. Electron paramagnetic resonance (EPR)/ spin trapping 
The generation of free radicals was monitored by electron paramagnetic resonance (EPR) 
spectroscopy using a Miniscope MS 100 (Magnettech, Berlin, Germany) spectrometer. 5,5-
Dimethyl-1-Pyrroline-N-Oxide (DMPO) was employed as the spin trapping agent. The instrument 
settings were the following: microwave power 10 mW, modulation 1000 mG, scan range 120 G and 
the centre of field approximately 3345 G.  
 
2.2.6.1 . Surface-driven Fenton reactivity (target molecule H2O2) 
SC45 was suspended in a H2O2 (0.04 M) buffered solution (potassium phosphate buffer, KPB 125 
mM, pH 7.4) at the dose of 45 mg/ml in the presence of DMPO (0.075 M) as spin-trapping agent. 
During the experiment, the suspension was continuously stirred. 50 μl of the suspension were 
withdrawn after 10, 30 and 60 minutes of incubation and the EPR spectra were recorded. The 
experiments were performed in triplicate. In order to assess the persistence of the reactivity of SC45 
after prolonged contact with biofluids, the same experiments were carried out on SC45 previously 
incubated with SBF for one week (SC45+SBF samples). Blanks experiments were performed in 
parallel in the absence of SC45 powders. 
 
2.2.6.2. Generation of carbon centred radicals (target molecule formate ion) 
SC45 was suspended in a sodium formate (1 M) buffered solution (KPB, 250 mM, pH 7.4) at the 
concentration of 45 mg/ml in the presence of DMPO (0.075 M) as spin-trapping agent. During the 
experiment, the suspension was continuously stirred. 50 μl of the suspension were withdrawn after 
10, 30 and 60 minutes of incubation and the EPR spectra were recorded. Same experiments were 
performed on SC45+SBF samples. The signals were double integrated and the values obtained were 
expressed as arbitrary units. Blanks experiments were performed in parallel in the absence of SC45 
powders. All the experiments were carried out in triplicate.  
   
2.2.7. Cell adhesion and proliferation tests 
Adhesion and proliferation studies were performed using 3T3 murine fibroblasts. The cells were 
cultured at 37 °C in 95% air, 5% CO2 in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% fetal bovine serum (Gibco, Invitrogen Corporation), 1% penicillin 
streptomycin solution (Cambrex) and 1% L-Glutamine (Cambrex); 
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SC45 and SC45+SBF (after one week of soaking in SBF) bulk samples were first sterilized in an 
oven at 180 °C for 3 h before the cellular tests. The cell density was 2 x 10
4
 cells/cm
2
 for adhesion 
tests and respectively 5 x 10
3
 cells/cm
2
 for proliferation tests. Both adhesion and proliferation tests 
were performed in triplicate. The negative control (CTR) was carried out on polystyrene without 
adding any glass-ceramic sample. After 3 h for adhesion and respectively 72 h for proliferation, the 
samples were rinsed twice in a phosphate buffered saline solution (PBS) and then stained with a 
0.025% Acridine Orange solution. Cell number, morphology and vitality on each material were 
analysed using a fluorescence microscope (Leitz Aristoplan) at 250x magnification. The resulted 
cell number is expressed as a mean of 10 random fields of 0.2 mm
2
 for each sample. The 
experiments were carried out in triplicate and thus 30 random fields (n=30) were analysed for each 
set of samples (SC45, SC45+SBF and CTR), for both adhesion and proliferation tests. The data 
were expressed as mean ± standard deviation. Considering CTR=100%, the relative percent of 3T3 
cells attached to SC45 and SC45+SBF samples can be calculated by dividing their corresponding 
mean cell numbers by the mean cell number of the control samples.  
Cell morphology was also studied by SEM analysis. In this case, a cell density of 1 x 10
4
 cells/cm
2
 
was used. After 36 h of culture, the cells were washed with 0.1M sodium cacodylate buffer and then 
fixed for 30 min at 4°C in a solution containing 4% paraformaldehyde and 2.5% glutaraldehyde in 
0,1M sodium cacodylate buffer, pH 7.4. The samples were then dehydrated in a series of ethanol 
solutions (50%, 70%, 85%, 95% and 100%) and fixed in hexamethyldisilazane. The obtained 
samples were gold coated using an ion sputter and then examined using a SEM Philips 525 
microscope at an accelerating voltage of 10 kV. 
 
2.2.8. Citotoxicity 
In-vitro cytotoxicity assessment of SC45 glass-ceramics was performed by qualitative evaluation of 
osteoblast cells morphology based on confluence, vacuolization and cell death analysis. U2OS 
human bone osteosarcoma cells were used for this purpose.  
Ferrimagnetic glass-ceramic powders before (SC45) and after one week of soaking in SBF 
(SC45+SBF) were sterilized at 180 °C for 3 h in an oven. U2OS cells were seeded into 6-wells 
plates at a density of 5 x 10
4
 cells/well in DMEM medium supplemented with 10% fetal bovine 
serum 1% penicillin streptomycin solution and 1% L-Glutamine at 37°C under a humidified 
atmosphere with 5% CO2. Different concentrations of glass-ceramic particles were suspended in 
serum free medium using an ultrasonic bath for 10min to prevent agglomeration. After 24h, the 
medium with 10% FBS was removed and replaced by 3 ml/well particle suspensions at the 
following dilutions: 1:10, 1:100, 1:1000, 1:10000 and 1:100000. Controls were carried out with 
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U2OS cells treated with an equivalent volume of serum-free medium (3ml/well) without any 
particles. Cells were incubated for further 72 h. After time intervals of 24 h, 48 h and 72 h of 
incubation with particle suspensions at different concentrations, cells were examined 
microscopically by using an inverted microscope (Olympus). The bright field images were recorded 
at 10X magnification.  
 
2.2.9. Statistical analysis 
The data are expressed as mean ± standard deviation. Statistical analysis of data was carried out 
using Student’s t-test, considering a statistical significance level of 0.05 (95% confidence interval). 
A calculated p-value higher than 0.05 (p>0.05) indicates no significant difference. 
 
3. Results 
 
3.1. X-ray diffraction  
Figure 1 displays a typical XRD pattern of SC45 glass-ceramic powder. This material contains only 
one crystalline phase, magnetite, which forms during cooling from the melting temperature. The 
quantity of magnetite crystals was evaluated in a previous work [12] and was estimated around 34 
wt%. The theoretical quantity of magnetite is 45 wt% and therefore, the rest of 11 wt% remain in 
the amorphous matrix.  
 
Figure 1 XRD spectrum of a SC45 powder sample (=magnetite) 
 
3.2. Scanning electron microscopy 
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SEM micrographs of the chemically etched surface of the SC45 glass-ceramic samples are shown in 
Figure 2. The acid solution removed the amorphous phase, leaving visible magnetite crystals. As 
can be seen, the magnetite is organised in small columns, formed by crystals with dimensions 
between 5-8µm (Figure 2.a). A higher magnification SEM image of the central part of the Figure 
2.a is presented in Figure 2.b. The foreground crystal has an octahedral shape, typical of cubic 
crystalline phases. Its mean size is 7.5 µm.  
 
    
a) 
 
b) 
Figure 2 SEM images of a SC45 bulk sample after chemical etching at different magnifications 
 
3.3. pH analysis 
The variation of the SC45 samples pH during soaking in SBF for one month is presented in Figure 
3. It can be noticed that the pH values of the powders sample are higher than the ones of the bulk 
samples. Considering the pH data with refresh, the slope of the powders variation (blue line in 
Figure 3) in the first week is assessed between 7.9 and 8, while for the bulk samples (green line in 
Figure 3) the slope is assessed between 7.5 and 7.6.  The powders have higher specific surface area 
and are much more reactive. Their pH has a rapid increase in the first two weeks of soaking, even if 
the SBF solution was refreshed twice/week. This can be explained by the fast ionic exchange 
between the powders surface and SBF solution, as discussed in the next sections. The highest pH 
value (8) is reached after one week in SBF. After two weeks, the pH starts to decrease, maintaining 
a slow variation around the 7.7 value, due to the lower ionic dissolution and SBF refresh. 
The pH of the bulk samples progressively increases during one month of soaking, reaching values 
under 7.7. There is no significant difference between the pH values of the bulk samples with or 
without the refresh (green and red lines in Figure 3).  
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Figure 3 pH variation of SC45 samples during SBF soaking (R=with refresh; NR=without refresh) 
 
3.4. Atomic absorption spectrophotometry (AAS) 
The variation of the concentration of Ca, Na, Si and Fe ions released in a SBF solution during one 
month of SC45 powders soaking at 37 °C is shown in Figure 4 (the vertical axis is a log10 scale). Na 
values are close to 10000 ppm (3-5 orders of magnitude higher than the other ions). Na is released 
from bioactive glass-ceramics due to the ionic exchange with the solution. SBF contains a high 
quantity of Na and the variation of this ion during one month is not significant due to the instrument 
limitation. On the contrary, the values of iron released in SBF at 37 °C are under 0.1 ppm (mg/l).  
 
 
Figure 4 Variation of concentration of different ions released in SBF solution during one month of 
SC45 powder immersion at 37°C (vertical axis is a log10 scale) 
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This result is quite important for the biocompatibility assessment of the SC45 glass-ceramics. Both 
Si and Ca values slightly increase during one month in SBF, due to the ionic exchange between the 
powders samples and solution.  
In order to analyse the concentration of these ions released in a basic (simplified) solution, distilled 
water was considered. The variation of the ions released at 37°C during two weeks of immersion of 
SC45 powders in distilled water can be seen in Figure 5.  
 
 
Figure 5 Variation of concentration of different ions released in distilled water solution during two 
weeks of SC45 powder immersion at 37°C (vertical axis is a log10 scale) 
 
In this case, Na concentration continuously increases after 3days and the slope is of three orders of 
magnitude (vertical axis is a log10 scale). Na concentration starts from under 1ppm values and 
reaches values around 80ppm after two weeks in distilled water, indicating a fast ions exchange. 
Silicon concentration rapidly increases during the first 3 days and after then displays a slow raise. 
Iron is completely released in the first day of soaking and after then its concentration remains 
almost constant. Fe values are also in this case under 0.1ppm. Ca concentration increases in the first 
24 h and after then slightly decreases up to values around 1ppm (after 2weeks). Therefore, 
considering the distilled water, Na and Ca exhibit a more evident variation of their concentration, 
compared with Si and Fe ions.  
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3.5. X-ray photoelectron spectroscopy (XPS) 
XPS spectra of the silicon, carbon and oxygen regions before (SC45 sample) and after 7days of pre-
treatment in SBF (SC45+SBF sample) are shown in Figure 6. 
 
 
Before the SBF treatment, the SC45 sample presents one silicon peak at around 102 eV, 
characteristic to silica glass (Figure 6.a). After SBF pre-treatment, XPS detects a new peak at higher 
energy (103.9 eV), typical of silica gel (Figure 6.b). Similarly, the carbon regions before (Figure 
6.c) and after SBF (Figure 6.d) are different. The carbon peak at around 286 eV was attributed to 
carbonates species. It can be noticed that this peak increases after immersing the samples in SBF. 
Before SBF soaking, the oxygen peak (Figure 6.e) was deconvoluted into three spectral bands at 
 
SC45      SC45+SBF 
a)Si2p       b)Si2p 
c)C1s        d) C1s 
e)O1s        f) O1s 
 
Figure 6 XPS graphics of the Si2p (a, b), C1s (c, d) and O1s (e, f) peaks for the SC45 samples 
before (a, c, e) and after one week of soaking in SBF (b, d, f). 
SiO2 SiO2 
SiO2 
SiO2 
oxides oxides 
silica gel 
carbonates 
carbonates 
hydroxyls/ 
silica gel 
hydroxyls/ 
silica gel 
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about 530 eV, 532 eV and 533 eV. The low energy peak at 530 eV is characteristic to oxygen in 
different metal oxides. The peak at 532 eV is attributed to oxygen in silica. The higher energy peak 
at approximately 533 eV is due to oxygen in silanols, hydroxyls or silica gel. After SBF pre-
treatment, the silica gel peak of the oxygen region (533 eV) considerably increases (Figure 6.f), in 
accordance with the results obtained for the silicon region. The silicon peak is monoenergetic 
before SBF and bienergetic after SBF, due to the formation of a silica gel layer on the sample 
surface. The increase of the carbonates peak after SBF pre-treatment indicates a possible formation 
of a thin layer of hydroxycarbonate apatite (HCA), according to the bioactivity mechanism of 
bioactive glasses [22]. 
  
3.6. Radical reactivity of SC45 towards molecules of biological relevance 
Two free radical driven reactions were employed to investigate the oxidative potential of SC45, 
namely: i) the Fenton-like reactivity towards H2O2, and ii) the rupture of a C-H bond in the formate 
molecule.  
In the first experiment, referred to as Fenton-like reaction, H2O2 is allowed to interact with redox–
reactive transition metal ions (generally iron) at the particles surface and the generation of HO• 
radicals is observed. The release of HO• may take place when a particle is exposed to the oxidative 
environment reach in H2O2 of lysosomal fluid following phagocytosis by macrophages and 
polymorphonucleated cells (PMN) [23]. Moreover it was observed that also osteoblasts can engulf 
particles through lysosomal-like elements [24].  
The second free radical reaction investigated is based on the cleavage of C-H bond of formate ion 
which is employed as a simple model of several biomolecules (including peptides, proteins and 
lipids). In the presence of reactive dusts, such reaction possibly occurs via a direct surface-assisted 
homolytic cleavage driven by redox-reactive transition metal (including iron) at the particles 
surface. The carbon centred radical produced, i.e. •CO–, reacts with DMPO forming a stable 
paramagnetic adduct which is detectable by EPR spectroscopy. The results obtained for both 
experiments are reported in Figure 7. Employing DMPO as spin-trapping agent, the ability of SC45 
to induce HO• radical upon contact with H2O2 was investigated. In Figure 7A the EPR spectrum 
recorded after 60 minutes of incubation shows the typical signal of DMPO-HO• adduct indicating 
that SC45 is able to react with H2O2 via a Fenton-like mechanism.  
In order to assess the persistence of such reactivity after contact with biofluids, the same experiment 
was carried out on SC45 previously incubated in SBF at 37 °C for one week (SC45 + SBF). Also in 
this case the EPR signal of DMPO-HO• adduct was recorded. The signal intensities are virtually the 
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same with both the samples indicating that one week of incubation with SBF did not decrease the 
surface Fenton-like reactivity of SC45.  
328 330 332 334 336 338 340 342
SC45+SBF
SC45
blank
 
 
field, mT
1000 A.U.
328 330 332 334 336 338 340 342
1000 A.U.
B
SC45+SBF
SC45
blank
 
field, mT
A
 
Figure 7  EPR spectra recorded after 60 minutes of incubation of a suspension of SC45 (45mg/ml) 
and SC45+SBF (45 mg/ml) in a potassium phosphate buffered solution (KPB, pH 7.4) of A) H2O2 
and B) sodium formate, in the presence of DMPO as spin trapping agent. Blank experiments were 
carried out in the same conditions without SC45 powders. 
 
In Figure 7.B the EPR spectra recorded after 60 minutes of incubation of SC45 with a buffered 
solution of sodium formate and DMPO are reported. A rather intense signal was detected. The 
effect of a prolonged contact with biofluids on the reactivity of SC45 was investigated employing 
SC45+SBF. In this case, no signal was detected indicating that the incubation in SBF caused the 
complete inactivation of the reactive centres responsible for such reactivity.   
 
3.7. Cell adhesion and proliferation tests 
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The average percentage of 3T3 fibroblast cells attached to the SC45 and SC45+SBF samples after 
3h of incubation is presented in Figure 8. These results are relative to the polystyrene control which 
was considered 100%. Therefore, around 60% of the cells adhered to the glass-ceramic surface. 
Considering the 95% confidence interval, there is no significant difference between the SC45 and 
SC45+SBF samples. 
 
Figure 8 Average percentage of 3T3 cells relative to the polystyrene control, attached to the 
materials after 3 hours (adhesion). CTR was considered 100%.  
 
Figure 9 shows the relative percent of 3T3 cells attached to the samples surface after 3 days of 
incubation. Around 25% cells proliferate on the SC45 samples, whereas for the SC45+SBF 
samples, around 45% of cells are attached. Therefore, almost two times more cells proliferated on 
the pre-treated samples.  
 
Figure 9 Average percentage of 3T3 cells relative to the polystyrene control, attached to the 
materials after 3 days (proliferation). CTR was considered 100%. 
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Student’s t-test shows a significant difference between the two sets of samples. The difference 
probably arises from different morphological surface features. The surface chemical reactions 
which occur during the SBF soaking modify the surface characteristics of the SC45+SBF glass-
ceramic samples, leading to a favourable environment for the biological species. 
SEM images of the 3T3 cells attached to the SC45+SBF and polystyrene control, after 36h of 
incubation are displayed in Figure 10. 
 
 
a) 
 
b) 
 
c) 
 
d) 
Figure 10 SEM images of the 3T3 cells attached to the SC45+SBF (a and b) and polystyrene 
control (c and d) after 36h 
 
It can be immediately noticed the different morphologies of the two surfaces: the rough and the 
irregular surface of the SC45+SBF sample (Figure 10.a and 10.b) in relation to the flat surface of 
the CTR (Figure 10.c and 10.d) sample. The cells grow normally on both substrates, spreading their 
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filopodia over the materials surface. Higher magnification images of fibroblast cells layer extended 
over the SC45+SBF and CTR samples can be seen in Figure 10.b and Figure 10.d, respectively. The 
cells size is larger for the CTR samples. Regarding the SC45+SBF substrate, the 3T3 cells maintain 
their morphological characteristics, with distinct flat shape and extended filopodia, but have smaller 
size compared to the CTR reference.  
 
3.8. Citotoxicity 
Optical microscopy panel images of the U2OS cells at different times of incubation, using SC45-
powders suspensions at different dilutions are presented in Figure 11. The results show that cells do 
not display a clear sign of apoptosis or major alterations in the cell growth. However, at lower 
dilution rates (1:10, 1:100) the number of cells grown into the well plates is much lower than the 
one for higher dilution rates. The morphology of the cells for higher dilution rates of the SC45-
powders suspensions (1:1000, 1:10000 and 1:100000) looks similar to the one of the control. The 
cells reach about 80% confluency after 72h of cells culture. For the 1:10 dilution rate, U2OS cells 
have around 30% confluency, whereas for 1:100 dilution rate they are about 40% confluency after 
72 h of incubation. It seems that the presence of SC45 particles agglomerations does not affect the 
cells attachment (see Figure 11.c, panel 48h, 1:10 dilution). Similar results were obtained for 
SC45+SBF-powders suspensions (Figure 12). Even for lower dilution rates, the cells morphology 
and density are similar to the ones of the control. A layer of normally spread cells can be observed 
for all samples (including 1:10 dilution one). This qualitative evaluation demonstrated no change of 
cellular morphology for cells exposed to SC45+SBF-powders suspensions. After 72h incubation, a 
confluent layer of cells was formed in all these wells.  
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a) 0h 
 
 
b) 24h 
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c) 48h 
 
 
d) 72h 
 
Figure 11 Optical microscopy panel images of the U2OS cells before (a) and after 24h (b), 
48h (c) and 72h (d) in SC45-powders suspensions at the following dilutions (DIL): 1:10; 1:100; 
1:1000; 1:10000; 1:100000. CTR- is the control sample without SC45-powders suspensions. All 
images are recorded at 10X magnification. 
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a)  0h 
 
 
b)  24h 
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c)  48h 
 
 
d) 72h 
 
Figure 12 Optical microscopy panel images of the U2OS cells before (a) and after 24h (b), 
48h (c) and 72h (d) in SC45+SBF-powders suspensions at the following dilutions (DIL): 1:10; 
1:100; 1:1000; 1:10000; 1:100000. CTR- is the control sample without SC45+SBF-powders 
suspensions. All images are recorded at 10X magnification. 
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4. Discussion 
 
The biological applications of magnetic materials require a previous evaluation of toxicity. These 
features depend on physical state, chemical composition and surface morphology. Thus, in vitro 
biological evaluation is a key factor for biocompatibility assessment of the ferrimagnetic glass-
ceramics.  
These ferrimagnetic glass-ceramics containing magnetite crystals have been studied in the past for 
hyperthermia applications. An accurate characterisation of these materials has been previously 
done. The microstructure, crystals morphology, thermal and magnetic properties, power loss and 
bioactivity behaviour of these glass-ceramic materials have been analysed in our previous studies 
[11, 12, 13, 14]. The process parameters have been optimised in order to obtain magnetite as the 
unique crystalline phase embedded into the amorphous structure. As shown in Figure 1, XRD 
analysis evidenced that magnetite was the only crystalline phase formed during cooling from the 
melting temperature. Magnetite crystals exhibited octahedral shape and dimensions less than 10µm 
(Figure 2). As shown in [12], not all the iron oxides crystallized as magnetite; around 11wt% 
remain inside the glassy phase. The effect of iron ions that might be released into surrounding 
tissues was studied by AAS. Due to higher specific area of powders samples compared to the bulk 
ones, the amount of ions released by powders is expected to be higher than the corresponding 
amount of bulk specimens. Therefore, the release of iron ions was analysed on powders samples in 
both SBF and distilled water fluids. The results showed that the iron concentration into both fluids 
at 37°C does not exceed 0.1mg/l, (see Figure 4 and Figure 5). Therefore, the presumable cytotoxic 
effect of these glass-ceramic due to the iron release is minimal. The concentration of silicon and 
calcium released into SBF solution slightly increases during one month of immersion at 37°C. 
These results are in agreement with the previous studies on the reaction kinetics of bioactive glasses 
[22]. On the first stages of immersion of a bioactive glass in an aqueous solution, an ion exchange 
process between the network-modifying ions and H3O
+
 ions occurs, followed by the breaking of the 
glass network. Breaking of -Si-O-Si-bonds involves the silica release into solution and the silanols 
formation. By polycondensation of the silanols, a silica-rich layer is formed on the glass surface. 
Due to the continuous ionic exchange process between the materials surface and solution, the 
concentration of calcium and phosphate ions released into SBF increases. When SBF solution 
becomes saturated with calcium and phosphate, these ions precipitate, forming a calcium phosphate 
rich layer, on the top of the silica gel layer. Later on, during the last stage of in vitro bioactivity 
reactions in acellular SBF, the calcium phosphate rich layer crystallizes to a hydroxycarbonate 
apatite (HCA) structure, incorporating carbonate anions from solution.  
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Therefore, the increase of Na, Ca and Si concentrations, determined by AAS studies (Figure 4 and 
Figure 5) is confirmed by Hench’s studies on the bioactivity mechanism. The ion exchange process 
leads to an increase of the pH value. In fact, Figure 3 shows a rapid increase of the pH during the 
SBF soaking for both bulk and powder samples. High values of pH, over the physiological limits, 
might damage the cellular membrane leading to cell death. To reduce the initial pH increase, the 
samples can be pre-treated into aqueous solutions before biological evaluation.  
XPS studies on the ferrimagnetic glass-ceramic samples (Figure 6) show the formation of a silica 
gel layer after SBF soaking, in accordance with AAS and pH measurements. The increase of the 
carbonates peak after SBF pre-treatment (Figure 6.d) indicates a possible formation of a thin layer 
of hydroxycarbonate apatite (HCA), according to the bioactivity mechanism of bioglasses.  
In order to assess the oxidative potential of SC-45, the free radical-mediated reactivity was 
measured. SC-45 exhibited the capability to generate HO• radical in the presence of H2O2 (Fenton-
like reactivity) (Figure 7.a), as well as to cleave the C-H bond of formate molecule (Figure 7.b). 
After pre-treatment with SBF the HO• radical yield remained unvaried, whereas the reactivity 
towards formate was completely suppressed. This difference can reside in the different nature of the 
reactive sites involved. It is expected that the prolonged contact with SBF promoted the oxidation of 
Fe
2+
surf to Fe
3+
surf at the surface of SC-45. Fenton reaction is driven by Fe
2+ 
following eq. (1): 
 
Fe
2+
surf + H2O2  Fe
3+
surf + OH
–
 + •OH (1) 
 
Moreover, H2O2 is able to reduce Fe
3+
surf  to Fe
2+
surf (eq.2); Fenton reaction is also observed in the 
presence of Fe
3+
 [25]: 
 
Fe
3+
surf + H2O2  Fe
2+
surf + •O2
–
 + 2H
+
 (2) 
 
This reaction restores the former supply of Fe
2+ 
surf oxidized to Fe
3+
surf in SBF. This can account for 
the sustained HO• release observed with SC45+SBF. At the contrary, the homolytic cleavage of C-
H bond of formate has been observed only with Fe
2+
 [25]. In our experimental conditions, the 
depletion of Fe
2+
surf  following its oxidation in SBF can account for the complete suppression of 
such reactivity.  
The SBF pre-treatment may stimulate different biological species, enhancing the materials 
integration [26]. Therefore, a comparison study between untreated and pre-treated samples was 
accomplished. Consequently, the in vitro biocompatibility of these ferrimagnetic glass-ceramics 
was assessed by using two set of samples: SC45 (untreated) and SC45+SBF (samples pre-treated in 
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SBF for one week). The results showed a better biological behaviour of the glass-ceramic sample 
pre-treated in SBF solution, compared with the untreated one. In fact, on the first stage of the 
biological assessment (adhesion test), no significant difference between the SC45 and SC45+SBF 
samples is obtained. Almost 60% of 3T3 cells adhered to the both substrate surfaces (Figure 8). 
Regarding the proliferation test, the percentage of the cells which grew on the SC45+SBF samples 
is higher than the one of the SC45 (Figure 9); about 80% more cells proliferated on the pre-treated 
samples. In this case, the t-test probability is less than 0.05, so the difference between the SC45 and 
SC45+SBF samples is significant. SC45+SBF samples favour the 3T3 proliferations, probably due 
to the silica gel layer formed on the samples surface after one week of SBF soaking. Figure10 
shows the typical observed morphologies of 3T3 cells after 36h of incubation. SEM images 
evidence the presence of healthy cells with a good level of spreading. A clear micrograph of the 
cells filopodia which spread over the SC45+SBF sample surfaces can be seen in Figure  10.b.  
To evaluate toxicity we performed bright field images with inverted microscope to analyze cell 
death (apoptosis) and cell density (cell growth) at 0h, 24h, 48h and 72h incubation. This qualitative 
evaluation demonstrated no change of cellular morphology for cells incubated with the 
ferrimagnetic glass-ceramic powders suspensions.  
Morphological examination of cells which had been incubated with SC45 powder suspensions does 
not reveal any cytotoxic effect (Figure 11). However, we observed a decrease of confluence for 
U2OS cells exposed to the 1:10 dilution rate at 48 and 72 hours; the cells maintain their normal flat 
morphology with a distinct cell shape, but were not longer confluent after 3 days of incubation.  
Incubation of U2OS cell lines with SC45+SBF powder suspensions at intervals of 24h, 48h and 72 
hours did not influence the morphology of the cells (Figure 12). A layer of normally spread cells 
can be observed with only minor changes of confluence, vacuolization and morphological 
parameters.  
 
5. Conclusions 
In vitro biological characterisation of a ferrimagnetic glass-ceramic containing magnetite crystals 
have been carried out by using two sets of samples: samples pre-treated in a simulating body fluid 
(SBF) and samples without the pre-treatment. The SBF pre-treatment induces the formation of a 
silica-gel layer on the materials surface, which stimulates the cellular function of biological species. 
The concentration of iron released into the SBF solution does not exceed 0.1mg/ml at 37°C, during 
one month of soaking. Free radical mediated reactivity has a recognized role in particle toxicity. 
HO• release (Fenton reactivity) and cleavage of C-H bond of formate ion were assessed as indexes 
of the oxidative potential of the SC45 glass-ceramic samples. SC45 was active in both the tests. Pre-
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treatment with SBF completely annealed the reactivity towards C-H bond of formate, very probably 
due to the oxidation of Fe
2+
surf
 
centres. Cell adhesion and proliferation tests were carried out on 3T3 
murine fibroblasts cell line. The adhesion test shows that there are not significant differences 
between the untreated and SBF treated samples during the first hours of incubation. The difference 
appears after one day of cell culture. The proliferation test reveals that there is a significant 
difference between the two sets of samples after 3days of incubation. About 80% more cells were 
attached to the pre-treated samples after 3days of incubation, compared to the untreated samples. 
Cytotoxicity was performed by qualitative evaluation using U2OS osteoblast cells. Morphological 
examination of cells does not reveal any cytotoxic effect. The cells incubated with untreated 
samples display a decrease of confluence. It seems that the SBF pre-treatment of these 
ferrimagnetic glass-ceramic acts as a surface activation process, which leads to an increase of the 
cells activity. 
In conclusion, the results reported in the present paper indicate that the SBF pre-treatment can 
contribute to an increase of the biocompatibility of SC45 glass-ceramics by modifying their surface 
reactivity. The SBF pre-treatment can be also considered as a surface activation process, which 
implies the stimulation of the cellular functions, facilitating the tissue integration.  
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In vitro biocompatibility of a ferrimagnetic glass-ceramic for hyperthermia application 
 
Highlights 
 In vitro characterisation of a ferrimagnetic glass-ceramic containing magnetite crystals have 
been carried out, before and after treatment in Simulated Body Fluid (SBF). 
 The SBF pre-treatment stimulates the cellular function and acts as a surface activation 
process, which increases the cells activity. 
 Pre-treatment with SBF annealed the reactivity towards C-H bond of formate.  
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